Clinical Trials Logo

Clinical Trial Summary

Chronic obstructive pulmonary disease (COPD), a common and complex disease characterized by persistent airflow limitation, is a leading cause of mortality worldwide. COPD and its comorbidity are associated with hypoxia condition. Further investigations on the cellular and molecular aspects of hypoxia in COPD should help to reveal the mechanisms underlying the development of this disease. Dysfunction of the erythrocyte, a main medium to transport oxygen through the blood, contributes to the prognosis and severity of COPD through hypoxia. It is proposed that dysregulated proteins in erythrocytes that impair oxygen transport may be involved in the development of COPD. However, a comprehensive study on altered proteins of erythrocytes in COPD is still lacking. Proteomics techniques and protein chip techniques provide a high throughput screening method to figure out characteristic inflammatory or metabolic markers of diseases. Therefore, this study is to evaluate the clinical significance of differential erythrocyte proteins in the course of COPD disease.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05376618
Study type Observational
Source Zhujiang Hospital
Contact
Status Completed
Phase
Start date July 15, 2021
Completion date July 15, 2022

See also
  Status Clinical Trial Phase
Completed NCT04545398 - Acute Meat and Alternative Intake (PRotEin DIet SatisfacTION Trial 3) N/A
Not yet recruiting NCT05622877 - The Proteomic Study and Early Intervention Study of Carotid Unstable Plaque Phase 1
Completed NCT04064268 - Anabolic Potential of 3-hydroxybutyrate (3-OHB) and Whey Protein in a Human Catabolic Inflammatory Disease Model N/A
Recruiting NCT04804618 - Proteomics Study of Mild Cognitive Impairment and Alzheimer's Disease
Not yet recruiting NCT04472754 - The Biological Basis of Phlegm Dampness Syndrome in Patients With Ischemic Strokeļ¼šA Saliva and Urine Proteomics Study